https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Diabetes-MS.jpg

Diabetes Market Size, Share & Trends Analysis | Global (United States and Europe) | 2019-2025 | MedSuite Series | Segmented by: Insulin Syringes, Insulin Pumps, Insulin Pens, and 6 more

  • Year: 2019
  • Scope: 2015-2025
  • Region: Europe, United States
  • Pages: 754
  • Type: MedSuite

Throughout this medical market research on the U.S. and European diabetes monitoring, treatment, and drug delivery markets, over 90 companies across 16 countries were analyzed. To conduct this research, our comprehensive methodology was utilized to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

Previously, the U.S. diabetes monitoring, treatment, and drug-delivery market was valued at $15.7 billion. However, an increase is projected over the forecast period to reach approximately $16.4 billion by 2025 at a CAGR of 0.6%. In comparison, Europe’s diabetes monitoring, treatment, and drug-delivery market was valued at  €6.8 billion. Similarly, the European market is expected to increase at a CAGR of 4.3% to exceed €9 billion by 2025.

The following segments for both the U.S. and the European diabetes markets are included within this MedSuite series: blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps.

MARKET DATA INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Market Drivers & Limiters
  • Market Forecasts Until 2025, and Historical Data to 2015
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

U.S. DIABETES CARE MARKET INSIGHTSU.S. Diabetes Market by Segment

Although the number of insulin-dependent diabetics is rising in the United States, which has continued to drive unit sales growth of the insulin market, insulin manufacturers have experienced tremendous backlash from consumers and diabetes associations regarding the unreasonable rise in insulin prices over the last several decades. Insulin prices in the United States are among the highest in the world, which has forced patients to extend the usage life of their insulin and choose cost-sensitive therapy options, such as human insulin. As a result, insulin prices are projected to decrease over the forecast period.

EUROPE’S DIABETES CARE MARKET INSIGHTS

Europe Diabetes Care Market GrowthGrowth is expected over the forecast period for the European market, driven by increasing unit sales and moderated by ASP depreciation.  The primary driver of growth will be the expanding diabetic population in Europe and the increasing number of patients that require various diabetes care devices to manage their disease on a daily basis. The largest segment was the insulin market, accounting for approximately 44% of the total market value. The insulin market includes long-acting insulin, ultra-long-acting insulin, rapid-acting insulin, premixed insulin, and human insulin.

U.S. and EUROPEAN DIABETES CARE MARKET SHARE INSIGHTS

Novo NordiskEli Lilly, and Sanofi controlled the U.S. diabetes care market. Novo Nordisk, Sanofi, and Roche led the European diabetes care market. U.S. and European Top Companies in Diabetes Care Market

Within both the U.S. and European markets, Novo Nordisk held the leading position in the ultra-long-acting insulin rapid-acting insulin markets and the second-leading position in the long-acting insulin, premixed insulin, and human insulin markets.

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. The covered countries are:

  • North America (United States)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Benelux (Belgium, Netherlands, and Luxembourg), Scandinavia (Denmark, Finland, Norway, and Sweden), Austria, Switzerland, and Portugal)

 

FREE Sample Report

For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData
TABLE OF CONTENTS I
LIST OF FIGURES VIII
LIST OF CHARTS XII
EXECUTIVE SUMMARY 1
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 12
KEY REPORT UPDATES 14
VERSION HISTORY 14
RESEARCH METHODOLOGY 15
Step 1: Project Initiation & Team Selection 15
Step 2: Prepare Data Systems and Perform Secondary Research 18
Step 3: Preparation for Interviews & Questionnaire Design 20
Step 4: Performing Primary Research 21
Step 5: Research Analysis: Establishing Baseline Estimates 23
Step 6: Market Forecast and Analysis 24
Step 7: Identify Strategic Opportunities 26
Step 8: Final Review and Market Release 27
Step 9: Customer Feedback and Market Monitoring 28
DISEASE OVERVIEW 29
2.1 INTRODUCTION 29
2.1.1 Types of Diabetes 29
2.1.2 Diabetes Complications 31
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 33
2.1.4 Signs and Symptoms 35
2.1.5 Diabetes Monitoring 37
2.1.6 Treatment 39
2.1.7 Drug Delivery Systems 41
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 42
3.1 MARKET OVERVIEW 42
3.2 TREND ANALYSIS BY SEGMENT 49
3.3 DRIVERS AND LIMITERS 54
3.3.1 Market Drivers 54
3.3.2 Market Limiters 54
3.4 COMPETITIVE MARKET SHARE ANALYSIS 57
3.5 MERGERS AND ACQUISITIONS 64
PATIENT DEMOGRAPHICS 65
4.1 PATIENT DEMOGRAPHICS 65
4.1.1 Diagnosed Diabetic Population by Type 65
4.1.2 Diagnosed Type 2 Diabetic Population by Type 67
4.1.3 Diagnosed Insulin-Dependent Diabetic Population by Type 69
4.2 INSTALLED BASE ANALYSIS AND FORECAST 71
4.2.1 Personal Glucose Monitoring Installed Base by Segment 71
4.2.2 Personal CGM Installed Base by Insulin Therapy 73
4.2.3 Insulin User Installed Base by Segment 75
4.2.4 Durable Pump Installed Base by Diabetes Type 77
4.2.5 Patch Pump Installed Base by Diabetes Type 79
4.2.6 MDI Installed Base by Segment 81
4.2.7 MDI Installed Base by Diabetes Type 83
BLOOD GLUCOSE METER MARKET 85
5.1 INTRODUCTION 85
5.2 MARKET OVERVIEW 86
5.3 MARKET ANALYSIS AND FORECAST 90
5.3.1 Personal Blood Glucose Meter Market 90
5.3.2 Professional Blood Glucose Meter Market 93
5.4 DRIVERS AND LIMITERS 95
5.4.1 Market Drivers 95
5.4.2 Market Limiters 95
5.5 COMPETITIVE MARKET SHARE ANALYSIS 97
BLOOD GLUCOSE TEST STRIP MARKET 100
6.1 INTRODUCTION 100
6.2 MARKET OVERVIEW 101
6.3 MARKET ANALYSIS AND FORECAST 105
6.3.1 Total Personal Blood Glucose Test Strip Market 105
6.3.1.1 Medicare/Medicaid Blood Glucose Test Strip Market 110
6.3.1.2 Managed Care Blood Glucose Test Strip Market 112
6.3.1.3 Cash Blood Glucose Test Strip Market 114
6.3.2 Professional Blood Glucose Test Strip Market 116
6.4 DRIVERS AND LIMITERS 118
6.4.1 Market Drivers 118
6.4.2 Market Limiters 118
6.5 COMPETITIVE MARKET SHARE ANALYSIS 120
LANCET MARKET 123
7.1 INTRODUCTION 123
7.2 MARKET OVERVIEW 124
7.3 MARKET ANALYSIS AND FORECAST 128
7.3.1 Personal Lancet Market 128
7.3.2 Professional Lancet Market 130
7.4 DRIVERS AND LIMITERS 132
7.4.1 Market Drivers 132
7.4.2 Market Limiters 132
7.5 COMPETITIVE MARKET SHARE ANALYSIS 134
CONTINUOUS GLUCOSE MONITORING MARKET 137
8.1 INTRODUCTION 137
8.2 MARKET OVERVIEW 139
8.3 MARKET ANALYSIS AND FORECAST 144
8.3.1 Total Personal Continuous Glucose Monitoring Market 144
8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market 147
8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market 150
8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market 152
8.3.2 Total Professional Continuous Glucose Monitoring Market 154
8.3.2.1 Professional Continuous Glucose Monitoring System Market 157
8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market 160
8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market 162
8.4 DRIVERS AND LIMITERS 164
8.4.1 Market Drivers 164
8.4.2 Market Limiters 165
8.5 COMPETITIVE MARKET SHARE ANALYSIS 166
8.5.1 Continuous Glucose Monitoring Market 166
8.5.2 Continuous Glucose Monitoring Market Installed Base Share 170
FLASH GLUCOSE MONITORING MARKET 172
9.1 INTRODUCTION 172
9.2 MARKET OVERVIEW 173
9.3 MARKET ANALYSIS AND FORECAST 177
9.3.1 Flash Glucose Monitoring Reader Market 177
9.3.2 Flash Glucose Monitoring Sensor Market 180
9.4 DRIVERS AND LIMITERS 182
9.4.1 Market Drivers 182
9.4.2 Market Limiters 182
9.5 COMPETITIVE MARKET SHARE ANALYSIS 184
INSULIN MARKET 186
10.1 INTRODUCTION 186
10.1.1 Insulin Types 186
10.1.1.1 Rapid-Acting Insulin Analog 186
10.1.1.2 Regular Human Insulin 187
10.1.1.3 Intermediate-Acting Human Insulin 187
10.1.1.4 Long-Acting Insulin Analog 187
10.1.1.5 Ultra-Long-Acting Insulin Analog 187
10.1.1.6 Premixed Insulin 187
10.2 MARKET OVERVIEW 189
10.3 MARKET ANALYSIS AND FORECAST 194
10.3.1 Total Insulin Market 194
10.3.2 Long-Acting Insulin Market 196
10.3.3 Ultra-Long-Acting Insulin Market 198
10.3.4 Rapid-Acting Insulin Market 200
10.3.5 Premixed Insulin Market 202
10.3.6 Human Insulin Market 204
10.4 DRIVERS AND LIMITERS 206
10.4.1 Market Drivers 206
10.4.2 Market Limiters 206
10.5 COMPETITIVE MARKET SHARE ANALYSIS 208
INSULIN PEN MARKET 211
11.1 INTRODUCTION 211
11.2 MARKET OVERVIEW 212
11.3 MARKET ANALYSIS AND FORECAST 216
11.3.1 Reusable Pen Market 216
11.3.2 Total Pen Needle Market 218
11.3.2.1 Conventional Pen Needle Market 220
11.3.2.2 Safety Pen Needle Market 222
11.4 DRIVERS AND LIMITERS 224
11.4.1 Market Drivers 224
11.4.2 Market Limiters 225
11.5 COMPETITIVE MARKET SHARE ANALYSIS 227
INSULIN SYRINGE MARKET 230
12.1 INTRODUCTION 230
12.2 MARKET OVERVIEW 231
12.3 MARKET ANALYSIS AND FORECAST 235
12.3.1 Conventional Insulin Syringe Market 235
12.3.2 Safety Insulin Syringe Market 237
12.4 DRIVERS AND LIMITERS 239
12.4.1 Market Drivers 239
12.4.2 Market Limiters 239
12.5 COMPETITIVE MARKET SHARE ANALYSIS 241
INSULIN PUMP MARKET 244
13.1 INTRODUCTION 244
13.1.1 Durable Insulin Pumps 244
13.1.2 Patch Insulin Pumps 244
13.1.3 Simple Insulin Pumps 245
13.2 MARKET OVERVIEW 246
13.3 INSTALLED BASE OVERVIEW 251
13.4 MARKET ANALYSIS AND FORECAST 255
13.4.1 Total Durable Insulin Pump Market 255
13.4.1.1 Durable Pump Market 257
13.4.1.2 Infusion Set Market 260
13.4.1.3 Pump Reservoir Market 262
13.4.2 Total Patch Insulin Pump Market 264
13.4.2.1 Patch Pump System Market 266
13.4.2.2 Insulin Pod Market 269
13.4.3 Simple Insulin Pump Market 271
13.5 DRIVERS AND LIMITERS 274
13.5.1 Market Drivers 274
13.5.2 Market Limiters 275
13.6 COMPETITIVE MARKET SHARE ANALYSIS 277
13.6.1 Insulin Pump Market 277
13.6.2 Durable Insulin Pump Market 280
13.6.3 Insulin Pump Market Installed Base Share 282
13.6.4 Emerging Competitors 284
ABBREVIATIONS 285
The Global Report Suite for Diabetes Monitoring, Treatment and Drug Delivery includes analysis on the following companies currently active in this market:
  • Abbott
  • ACON Laboratories
  • AgaMatrix
  • Allison Medical
  • ApexBio
  • Arcadia Group
  • ARKRAY
  • Artsana
  • Ascensia
  • B. Braun
  • Becton Dickinson
  • Bionime
  • Biosense Medical Devices
  • Boehringer Ingelheim
  • Cambridge Sensors
  • CanAm
  • CVS
  • DarioHealth
  • Dexcom
  • Diabetic Supply of Suncoast
  • Eli Lilly
  • Excel International
  • Fifty 50 Medical
  • ForaCare
  • Genesis Health Technologies
  • Gluco Perfect
  • GlucoRx
  • Hekka
  • Home Aide Diagnostics
  • iHealth Labs
  • Infopia
  • Inside Biometrics
  • Insulet
  • Intuity Medical
  • i-SENS
  • Klinion
  • LifeScan
  • Livongo Health
  • Matz Medical
  • McKesson
  • Medicina
  • Medical Plastic Devices
  • MediPurpose
  • Medline
  • Medtronic
  • Menarini
  • Mendor
  • MyGlucoHealth
  • NeedleBay
  • Neon Diagnostics
  • Nipro
  • Nova Biomedical
  • Novo Nordisk
  • Oak Tree Health
  • Omnis Health
  • One Drop
  • Owen Mumford
  • Palmdoc
  • Perrigo
  • Pharma Supply
  • Philosys
  • Platinum Equity
  • Playtex
  • Prodigy
  • Prosum Medical
  • RAYS
  • Retractable Technologies
  • Roche
  • Sanofi
  • SD BIOSENSOR
  • Senseonics
  • Simple Diagnostics
  • Smart Meter
  • Smiths Medical
  • Specialty Medical Supplies
  • Spirit Healthcare
  • SPRINT MOTO
  • STAT Medical Devices
  • Suresign
  • Tandem
  • Telcare
  • Terumo
  • Trivia Health
  • Troge
  • U.S. Diagnostics
  • UltiMed
  • Unilife Medical Solutions
  • Valeritas
  • Vertex Diagnostics
  • Walmart
  • Ypsomed
 

LIST OF CHARTS

Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment,  U.S., 2015 – 2025 3
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview,  U.S., 2018 & 2025 3
Chart 3 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2015 – 2025 46
Chart 3 2: Diabetes Monitoring, Treatment and Drug Delivery Market Breakdown, U.S., 2018 47
Chart 3 3: Diabetes Monitoring, Treatment and Drug Delivery Market Breakdown, U.S., 2025 48
Chart 3 4: Growth Rates by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016 – 2025 53
Chart 3 5: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2018 63
Chart 4 1: Diagnosed Diabetic Population by Type, U.S., 2015 – 2025 66
Chart 4 2: Diagnosed Type 2 Diabetic Population by Type, U.S., 2015 – 2025 68
Chart 4 3: Diagnosed Insulin-Dependent Diabetic Population by Type, U.S., 2015 – 2025 70
Chart 4 4: Glucose Monitoring Installed Base by Segment, U.S., 2015 – 2025 72
Chart 4 5: CGM Installed Base by Segment by Insulin Therapy, U.S., 2015 – 2025 74
Chart 4 6: Insulin User Installed Base by Segment, U.S., 2015 – 2025 76
Chart 4 7: Durable Pump Installed Base by Diabetes Type, U.S., 2015 – 2025 78
Chart 4 8: Patch Pump Installed Base by Diabetes Type, U.S., 2015 – 2025 80
Chart 4 9: MDI Installed Base by Segment, U.S., 2015 – 2025 82
Chart 4 10: MDI Installed Base by Diabetes Type, U.S., 2015 – 2025 84
Chart 5 1: Blood Glucose Meter Market by Segment, U.S., 2015 – 2025 87
Chart 5 2: Blood Glucose Meter Market Breakdown, U.S., 2018 88
Chart 5 3: Blood Glucose Meter Market Breakdown, U.S., 2025 89
Chart 5 4: Personal Blood Glucose Meter Market, U.S., 2015 – 2025 92
Chart 5 5: Professional Blood Glucose Meter Market, U.S., 2015 – 2025 94
Chart 5 6: Leading Competitors, Blood Glucose Meter Market, U.S., 2018 99
Chart 6 1: Blood Glucose Test Strip Market by Segment, U.S., 2015 – 2025 102
Chart 6 2: Blood Glucose Test Strip Market Breakdown, U.S., 2018 103
Chart 6 3: Blood Glucose Test Strip Market Breakdown, U.S., 2025 104
Chart 6 4: Total Personal Blood Glucose Test Strip Market by Segment, U.S., 2015 – 2025 107
Chart 6 5: Total Personal Blood Glucose Test Strip Market, U.S., 2015 – 2025 109
Chart 6 6: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2015 – 2025 111
Chart 6 7: Managed Care Blood Glucose Test Strip Market, U.S., 2015 – 2025 113
Chart 6 8: Cash Blood Glucose Test Strip Market, U.S., 2015 – 2025 115
Chart 6 9: Professional Blood Glucose Test Strip Market, U.S., 2015 – 2025 117
Chart 6 10: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2018 122
Chart 7 1: Lancet Market by Segment, U.S., 2015 – 2025 125
Chart 7 2: Lancet Market Breakdown, U.S., 2018 126
Chart 7 3: Lancet Market Breakdown, U.S., 2025 127
Chart 7 4: Personal Lancet Market, U.S., 2015 – 2025 129
Chart 7 5: Professional Lancet Market, U.S., 2015 – 2025 131
Chart 7 6: Leading Competitors, Lancet Market, U.S., 2018 136
Chart 8 1: Continuous Glucose Monitoring Market by Segment, U.S., 2015 – 2025 141
Chart 8 2: Continuous Glucose Monitoring Market Breakdown, U.S., 2018 142
Chart 8 3: Continuous Glucose Monitoring Market Breakdown, U.S., 2025 143
Chart 8 4: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2015 – 2025 146
Chart 8 5: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2015 – 2025 149
Chart 8 6: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2015 – 2025 151
Chart 8 7: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2015 – 2025 153
Chart 8 8: Total Professional Continuous Glucose Monitoring Market by Segment, U.S., 2015 – 2025 156
Chart 8 9: Professional Continuous Glucose Monitoring System Market, U.S., 2015 – 2025 159
Chart 8 10: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2015 – 2025 161
Chart 8 11: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2015 – 2025 163
Chart 8 12: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2018 169
Chart 8 13: Leading Competitors, Continuous Glucose Monitoring Market Installed Base Share, U.S., 2018 171
Chart 9 1: Flash Glucose Monitoring Market by Segment, U.S., 2015 – 2025 174
Chart 9 2: Flash Glucose Monitoring Market Breakdown, U.S., 2018 175
Chart 9 3: Flash Glucose Monitoring Market Breakdown, U.S., 2025 176
Chart 9 4: Flash Glucose Monitoring Reader Market, U.S., 2015 – 2025 179
Chart 9 5: Flash Glucose Monitoring Sensor Market, U.S., 2015 – 2025 181
Chart 9 6: Leading Competitors, Flash Glucose Monitoring Market, U.S., 2018 185
Chart 10 1: Insulin Market by Segment, U.S., 2015 – 2025 191
Chart 10 2: Insulin Market Breakdown, U.S., 2018 192
Chart 10 3: Insulin Market Breakdown, U.S., 2025 193
Chart 10 4: Total Insulin Market, U.S., 2015 – 2025 195
Chart 10 5: Long-Acting Insulin Market, U.S., 2015 – 2025 197
Chart 10 6: Ultra-Long-Acting Insulin Market, U.S., 2015 – 2025 199
Chart 10 7: Rapid-Acting Insulin Market, U.S., 2015 – 2025 201
Chart 10 8: Premixed Insulin Market, U.S., 2015 – 2025 203
Chart 10 9: Human Insulin Market, U.S., 2015 – 2025 205
Chart 10 10: Leading Competitors, Insulin Market, U.S., 2018 210
Chart 11 1: Insulin Pen Market by Segment, U.S., 2015 – 2025 213
Chart 11 2: Insulin Pen Market Breakdown, U.S., 2018 214
Chart 11 3: Insulin Pen Market Breakdown, U.S., 2025 215
Chart 11 4: Reusable Pen Market, U.S., 2015 – 2025 217
Chart 11 5: Total Pen Needle Market by Segment, U.S., 2015 – 2025 219
Chart 11 6: Conventional Pen Needle Market, U.S., 2015 – 2025 221
Chart 11 7: Safety Pen Needle Market, U.S., 2015 – 2025 223
Chart 11 8: Leading Competitors, Insulin Pen Market, U.S., 2018 229
Chart 12 1: Insulin Syringe Market by Segment, U.S., 2015 – 2025 232
Chart 12 2: Insulin Syringe Market Breakdown, U.S., 2018 233
Chart 12 3: Insulin Syringe Market Breakdown, U.S., 2025 234
Chart 12 4: Conventional Insulin Syringe Market, U.S., 2015 – 2025 236
Chart 12 5: Safety Insulin Syringe Market, U.S., 2015 – 2025 238
Chart 12 6: Leading Competitors, Insulin Syringe Market, U.S., 2018 243
Chart 13 1: Insulin Pump Market by Segment, U.S., 2015 – 2025 248
Chart 13 2: Insulin Pump Market Breakdown, U.S., 2018 249
Chart 13 3: Insulin Pump Market Breakdown, U.S., 2025 250
Chart 13 4: Insulin Pump Market Installed Base by Segment, U.S., 2015 – 2025 252
Chart 13 5: Insulin Pump Market Installed Base Breakdown, U.S., 2018 253
Chart 13 6: Insulin Pump Market Installed Base Breakdown, U.S., 2025 254
Chart 13 7: Durable Insulin Pump Market by Segment, U.S., 2015 – 2025 256
Chart 13 8: Durable Pump Market, U.S., 2015 – 2025 259
Chart 13 9: Infusion Set Market, U.S., 2015 – 2025 261
Chart 13 10: Pump Reservoir Market, U.S., 2015 – 2025 263
Chart 13 11: Patch Insulin Pump Market by Segment, U.S., 2015 – 2025 265
Chart 13 12: Patch Pump System Market, U.S., 2015 – 2025 268
Chart 13 13: Insulin Pod Market, U.S., 2015 – 2025 270
Chart 13 14: Simple Insulin Pump Market, U.S., 2015 – 2025 273
Chart 13 15: Leading Competitors, Insulin Pump Market, U.S., 2018 279
Chart 13 16: Leading Competitors, Durable Insulin Pump Market, U.S., 2018 281
Chart 13 17: Leading Competitors, Insulin Pump Market Installed Base Share, U.S., 2018 283

LIST OF FIGURES

Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2018 (1 of 2) 4
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2018 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, U.S., 2018 (1 of 2) 6
Figure 1 4: Companies Researched in this Report, U.S., 2018 (2 of 2) 7
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 8
Figure 1 6: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 9
Figure 1 7: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016 – 2019 (1 of 2) 10
Figure 1 8: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016 – 2019 (2 of 2) 11
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered (1 of 2) 12
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered (2 of 2) 13
Figure 1 11: Key Report Updates 14
Figure 1 12: Version History 14
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2019 30
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2019 34
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2019 36
Figure 3 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2015 – 2025 (US$M) (1 of 2) 44
Figure 3 2: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2015 – 2025 (US$M) (2 of 2) 45
Figure 3 3: Diabetes Monitoring, Treatment and Drug Delivery Market Growth by Segment, U.S., 2015 – 2025 (1 of 2) 51
Figure 3 4: Diabetes Monitoring, Treatment and Drug Delivery Market Growth by Segment, U.S., 2015 – 2025 (2 of 2) 52
Figure 3 5: Drivers and Limiters, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2018 56
Figure 3 6: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2018 (1 of 2) 61
Figure 3 7: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2018 (2 of 2) 62
Figure 4 1: Diagnosed Diabetic Population by Type, U.S., 2015 – 2025 65
Figure 4 2: Diagnosed Type 2 Diabetic Population by Type, U.S., 2015 – 2025 67
Figure 4 3: Diagnosed Insulin-Dependent Diabetic Population by Type, U.S., 2015 – 2025 69
Figure 4 4: Glucose Monitoring Installed Base by Segment, U.S., 2015 – 2025 71
Figure 4 5: CGM Installed Base by Segment by Insulin Therapy, U.S., 2015 – 2025 73
Figure 4 6: Insulin User Installed Base by Segment, U.S., 2015 – 2025 75
Figure 4 7: Durable Pump Installed Base by Diabetes Type, U.S., 2015 – 2025 77
Figure 4 8: Patch Pump Installed Base by Diabetes Type, U.S., 2015 – 2025 79
Figure 4 9: MDI Installed Base by Segment, U.S., 2015 – 2025 81
Figure 4 10: MDI Installed Base by Diabetes Type, U.S., 2015 – 2025 83
Figure 5 1: Blood Glucose Meter Market by Segment, U.S., 2015 – 2025 (US$M) 86
Figure 5 2: Personal Blood Glucose Meter Market, U.S., 2015 – 2025 91
Figure 5 3: Professional Blood Glucose Meter Market, U.S., 2015 – 2025 93
Figure 5 4: Drivers and Limiters, Blood Glucose Meter Market, U.S., 2018 96
Figure 5 5: Leading Competitors, Blood Glucose Meter Market, U.S., 2018 98
Figure 6 1: Blood Glucose Test Strip Market by Segment, U.S., 2015 – 2025 (US$M) 101
Figure 6 2: Total Personal Blood Glucose Test Strip Market by Segment, U.S., 2015 – 2025 (US$M) 106
Figure 6 3: Total Personal Blood Glucose Test Strip Market, U.S., 2015 – 2025 108
Figure 6 4: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2015 – 2025 110
Figure 6 5: Managed Care Blood Glucose Test Strip Market, U.S., 2015 – 2025 112
Figure 6 6: Cash Blood Glucose Test Strip Market, U.S., 2015 – 2025 114
Figure 6 7: Professional Blood Glucose Test Strip Market, U.S., 2015 – 2025 116
Figure 6 8: Drivers and Limiters, Blood Glucose Test Strip Market, U.S., 2018 119
Figure 6 9: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2018 121
Figure 7 1: Lancet Market by Segment, U.S., 2015 – 2025 (US$M) 124
Figure 7 2: Personal Lancet Market, U.S., 2015 – 2025 128
Figure 7 3: Professional Lancet Market, U.S., 2015 – 2025 130
Figure 7 4: Drivers and Limiters, Lancet Market, U.S., 2018 133
Figure 7 5: Leading Competitors, Lancet Market, U.S., 2018 135
Figure 8 1: Continuous Glucose Monitoring Market by Segment, U.S., 2015 – 2025 (US$M) 140
Figure 8 2: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2015 – 2025 (US$M) 145
Figure 8 3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2015 – 2025 148
Figure 8 4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2015 – 2025 150
Figure 8 5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2015 – 2025 152
Figure 8 6: Total Professional Continuous Glucose Monitoring Market by Segment, U.S.,  2015 – 2025 (US$M) 155
Figure 8 7: Professional Continuous Glucose Monitoring System Market, U.S., 2015 – 2025 158
Figure 8 8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2015 – 2025 160
Figure 8 9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2015 – 2025 162
Figure 8 10: Drivers and Limiters, Continuous Glucose Monitoring Market, U.S., 2018 165
Figure 8 11: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2018 168
Figure 8 12: Leading Competitors, Continuous Glucose Monitoring Market Installed Base Share, U.S., 2018 170
Figure 9 1: Flash Glucose Monitoring Market by Segment, U.S., 2015 – 2025 (US$M) 173
Figure 9 2: Flash Glucose Monitoring Reader Market, U.S., 2015 – 2025 178
Figure 9 3: Flash Glucose Monitoring Sensor Market, U.S., 2015 – 2025 180
Figure 9 4: Drivers and Limiters, Flash Glucose Monitoring Market, U.S., 2018 183
Figure 9 5: Leading Competitors, Flash Glucose Monitoring Market, U.S., 2018 184
Figure 10 1: Onset, Peak and Duration of Insulin Types, U.S., 2018 188
Figure 10 2: Insulin Market by Segment, U.S., 2015 – 2025 (US$M) 190
Figure 10 3: Total Insulin Market, U.S., 2015 – 2025 194
Figure 10 4: Long-Acting Insulin Market, U.S., 2015 – 2025 196
Figure 10 5: Ultra-Long-Acting Insulin Market, U.S., 2015 – 2025 198
Figure 10 6: Rapid-Acting Insulin Market, U.S., 2015 – 2025 200
Figure 10 7: Premixed Insulin Market, U.S., 2015 – 2025 202
Figure 10 8: Human Insulin Market, U.S., 2015 – 2025 204
Figure 10 9: Drivers and Limiters, Insulin Market, U.S., 2018 207
Figure 10 10: Leading Competitors, Insulin Market, U.S., 2018 209
Figure 11 1: Insulin Pen Market by Segment, U.S., 2015 – 2025 (US$M) 212
Figure 11 2: Reusable Pen Market, U.S., 2015 – 2025 216
Figure 11 3: Total Pen Needle Market by Segment, U.S., 2015 – 2025 (US$M) 218
Figure 11 4: Conventional Pen Needle Market, U.S., 2015 – 2025 220
Figure 11 5: Safety Pen Needle Market, U.S., 2015 – 2025 222
Figure 11 6: Drivers and Limiters, Insulin Pen Market, U.S., 2018 226
Figure 11 7: Leading Competitors, Insulin Pen Market, U.S., 2018 228
Figure 12 1: Insulin Syringe Market by Segment, U.S., 2015 – 2025 (US$M) 231
Figure 12 2: Conventional Insulin Syringe Market, U.S., 2015 – 2025 235
Figure 12 3: Safety Insulin Syringe Market, U.S., 2015 – 2025 237
Figure 12 4: Drivers and Limiters, Insulin Syringe Market, U.S., 2018 240
Figure 12 5: Leading Competitors, Insulin Syringe Market, U.S., 2018 242
Figure 13 1: Insulin Pump Market by Segment, U.S., 2015 – 2025 (US$M) 247
Figure 13 2: Insulin Pump Market Installed Base by Segment, U.S., 2015 – 2025 251
Figure 13 3: Durable Insulin Pump Market by Segment, U.S., 2015 – 2025 (US$M) 255
Figure 13 4: Durable Pump Market, U.S., 2015 – 2025 258
Figure 13 5: Infusion Set Market, U.S., 2015 – 2025 260
Figure 13 6: Pump Reservoir Market, U.S., 2015 – 2025 262
Figure 13 7: Patch Insulin Pump Market by Segment, U.S., 2015 – 2025 (US$M) 264
Figure 13 8: Patch Pump System Market, U.S., 2015 – 2025 267
Figure 13 9: Insulin Pod Market, U.S., 2015 – 2025 269
Figure 13 10: Simple Insulin Pump Market, U.S., 2015 – 2025 272
Figure 13 11: Drivers and Limiters, Insulin Pump Market, U.S., 2018 276
Figure 13 12: Leading Competitors, Insulin Pump Market, U.S., 2018 278
Figure 13 13: Leading Competitors, Insulin Pump Market Installed Base Share, U.S., 2018 282
Figure 13 14: Emerging Competitors, Insulin Pump Market, U.S., 2018 284

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology